Read more
10:20 AM · 5 August 2024

JAP225 plunges 11.50% 🔴

Panic in Japanese stocks reaches record levels, surpassing the sell-off from March 2020 during the Covid-19 pandemic. The index is down 11.50% just today and has fallen over 28% from its peaks, confirming a transition into a bear market. Nikkei 225 futures have been suspended due to the activation of an automatic circuit breaker.

The declines in the Japanese market are accelerated by the rise in the value of the Japanese yen, which is the strongest currency today, gaining even between 3.0-5.0% against other G10 currencies. USDJPY is down 3.20% to 141.8000.

  • Despite the BOJ's rate hike, the yield on 10-year Japanese government bonds fell by over 25 basis points to a multi-month low.

  • The yen rose to multi-month highs against the dollar, affecting exporters like Honda Motor and real estate companies like Mitsui Fudosan, reversing earlier stock market gains.

  • Foreign investors sold a net 1.56 trillion yen in Japanese stocks and futures, contributing to the market downturn.

The Japanese market is heading towards the worst trading day in the entire history of the stock exchange. The declines are also accelerated by investor panic, with trading in Nikkei 225 futures already suspended twice due to the automatic halt. The volatility index has risen to a new record of 132%. The Japanese Topix is experiencing its worst day since 1987.

Source: xStation 5

24 April 2026, 9:53 PM

Daily summary: AI optimism, Nvidia stock surge & second round of US - Iran talks drive optimism on Wall Street

24 April 2026, 6:58 PM

🔴Three markets to watch next week: all eyes on the Fed (24.04.2026)

24 April 2026, 6:40 PM

US Open: Nasdaq surges as semiconductor stocks improve sentiments on Wall Street

24 April 2026, 4:45 PM

Market Wrap: Indices try to recover on US-Iran negotiations hopes 🇪🇺 SAP surges 6% after earnings 📈

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.